If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSegro Regulatory News (SGRO)

Share Price Information for Segro (SGRO)

Share Price is delayed by 15 minutes
Get Live Data
870.00    -10.00 (-1.14%)
Bid:
869.40
Ask:
869.80
Spread: 0.40 (0.046%)
Market Cap: £11.77b
SGRO Live PriceLast checked at - London Stock Exchange

Intraday Segro Share Chart

Form 8 (OPD)

Today 11:13

RNS Number : 1741L
SEGRO PLC
06 July 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

SEGRO PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SEGRO PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 JULY 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - PROLOGIS, INC.

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 10 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

-

NIL

-

(2) Cash-settled derivatives:

 

NIL

-

NIL

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

-

NIL

-

 

TOTAL:

NIL

-

NIL

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NONE

Details, including nature of the rights concerned and relevant percentages:

NONE

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(a) Interests held by directors of SEGRO plc and their close relatives and related trusts

 

Name

No. of ordinary shares

Percentage of total issued share capital*

Andrew Harrison

564,755

0.04%

Carol Ann Fairweather

20,000

0.00%

David John Rivers Sleath

1,277,499

0.09%

Dr. Linda Yi-Chuang Yueh

4,716[1]

0.00%

Marcus Sperber

11,137

0.00%

Mary Elizabeth Barnard

12,5072

0.00%

Simon William David Fraser

31,440

0.00%

Susan Vivien Clayton

8,0133

0.00%

Susanne Dorothee Schroeter

1,941

0.00%

 

* Figures are rounded down to two decimal places and are calculated on the basis of SEGRO plc having 1,354,073,367 ordinary shares of 10 pence each in issue (as set out in SEGRO plc's announcement dated 1 July 2026).

[1] 1,559 ordinary shares held by a close relative of Dr. Linda Yi-Chuang Yueh.

2 Held by a close relative of Mary Elizabeth Barnard.

3 1,013 ordinary shares held by a close relative of Susan Vivien Clayton.

 

(b) Interests held as options or awards under the share plans of SEGRO plc by the directors of SEGRO plc and their close relatives and related trusts

 

Name

Share plan under which option or award was granted1

No. of ordinary shares in SEGRO plc under option or subject to award1

Date of grant

Exercise price (pence)

Vesting date(s)2

Expiry date

David John Rivers Sleath

LTIP

264,001

22 March 2024

Nil

22 March 2027

-

335,378

19 February 2025

Nil

19 February 2028

-

304,181

25 February 2026

Nil

25 February 2029

-

Sharesave

3,035

15 April 2026

599.52

1 June 2029 

1 December 2029

Susanne Dorothee Schroeter

LTIP

128,385

2 December 2025

Nil

19 February 2028

-

105,5143

2 December 2025

Nil

31 March 2027; 31 March 2028

-

169,585

25 February 2026

Nil

25 February 2029

-

Sharesave

3,035

15 April 2026

599.52

1 June 2029

1 December 2029

 

[1] LTIP awards are structured as conditional awards over ordinary shares. Sharesave is an HMRC approved option scheme.

 

2 LTIP awards are subject to a three-year performance period followed by a two-year post-vesting holding period.

 

3 Granted as a recruitment LTIP award on Susanne Dorothee Schroeter's appointment as an executive director of

SEGRO plc, vesting in two equal tranches (50 per cent on 31 March 2027 and 50 per cent on 31 March 2028,

subject to continued employment) and not subject to performance conditions or a post-vesting holding period.

 

 

(c) Interests of connected advisers

 

Name

No. of ordinary shares

Percentage of total issued share capital

Calvert Research and Management1

103,474

0.008

 

[1] Calvert Research and Management is a group company of Morgan Stanley.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

6 July 2026

Contact name:

Stephanie Murton

Telephone number:

+44 207 451 9082

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUNVKRNKUBRRR
Date   Source Headline
6th Jul 20265:39 pmRNSForm 8.5 (EPT/RI) - SEGRO plc
6th Jul 20264:29 pmRNSForm 8.5 (EPT/RI) - SEGRO plc
6th Jul 20264:28 pmRNSForm 8.5 (EPT/RI) - Replacement of SEGRO plc
6th Jul 20263:25 pmRNSForm 8.3 - SEGRO PLC
6th Jul 20263:20 pmRNSForm 8.3 - SEGRO plc
6th Jul 20262:18 pmRNSForm 8.3 - SEGRO plc
6th Jul 20262:00 pmRNSForm 8.3 - Prologis, Inc.
6th Jul 20262:00 pmRNSForm 8.3 - SEGRO plc
6th Jul 20262:00 pmPRNInvesco Ltd: Form 8.3 - Segro PLC; Public dealing disclosure
6th Jul 202612:01 pmRNSForm 8.5 (EPT/NON-RI) - Segro Plc
6th Jul 202611:58 amRNSForm 8.5 (EPT/RI) - Segro Plc
6th Jul 202611:58 amRNSForm 8.5 (EPT/RI) - Segro Plc Replacement
6th Jul 202611:33 amRNSForm 8.5 (EPT/RI) - Segro PLC
6th Jul 202611:24 amRNSForm 8.5 (EPT/NON-RI) - Segro PLC
6th Jul 202611:13 amRNSForm 8 (OPD)
6th Jul 202611:07 amRNSForm 8 (OPD) (Prologis)
6th Jul 202610:58 amRNSForm 8.5 (EPT/RI) - SEGRO plc
6th Jul 202610:56 amRNSForm 8.5 (EPT/RI) - SEGRO plc
6th Jul 202610:55 amRNS20260703_SEGRO PLC_8.5 EPT NON-RI_UK_BOFASE.
6th Jul 202610:49 amRNSForm 8.5 (EPT/NON-RI) - SEGRO plc
6th Jul 202610:48 amRNS20260703_SEGRO PLC_8.5 EPT RI_UK_MLI
6th Jul 202610:38 amRNSForm 8.5 (EPT/RI)-SEGRO plc
3rd Jul 20264:42 pmRNSForm 8.5 (EPT/NON-RI) - SEGRO PLC
3rd Jul 20264:31 pmRNSForm 8.3- Replacement Prologis, Inc.
3rd Jul 20263:25 pmRNSForm 8.3 SEGRO PLC
3rd Jul 20263:20 pmRNSForm 8.3 - SEGRO plc
3rd Jul 20263:07 pmRNSForm 8.3 - Prologis/SEGRO
3rd Jul 20263:06 pmRNSForm 8.3 - Prologis, Inc.
3rd Jul 20263:06 pmRNSForm 8.3 - PROLOGIS INC
3rd Jul 20263:04 pmRNSForm 8.3 (Prologis/SEGRO)
3rd Jul 20263:00 pmRNSForm 8.3 - Prologis, Inc
3rd Jul 20262:58 pmRNSForm 8.3- Prologis, Inc.
3rd Jul 20262:57 pmRNSForm 8.3-SEGRO plc
3rd Jul 20262:56 pmRNSForm 8.3 Prologis Inc
3rd Jul 20262:56 pmRNSForm 8.3- SEGRO plc
3rd Jul 20262:47 pmRNSForm 8.3 - SEGRO plc
3rd Jul 20262:45 pmRNSForm 8.3 - Segro Plc
3rd Jul 20262:43 pmPRNInvesco Ltd: Form 8.3 - Segro PLC; Public dealing disclosure
3rd Jul 20262:32 pmEQSForm 8.3 - The Vanguard Group, Inc.: SEGRO plc
3rd Jul 20262:26 pmRNSForm 8.3 - Prologis Inc.
3rd Jul 20262:00 pmRNSForm 8.3 Segro Plc
3rd Jul 20261:43 pmRNSForm 8.5 (EPT/RI) - Replacement of SEGRO plc
3rd Jul 20261:40 pmRNSForm 8.5 (EPT/RI) - Replacement of SEGRO plc
3rd Jul 20261:09 pmRNSForm 8.3 - SEGRO PLC
3rd Jul 202612:26 pmRNSForm 8.3 - SEGRO plc
3rd Jul 202612:22 pmRNSForm 8.3 - SEGRO plc
3rd Jul 202611:58 amRNSForm 8.5 (EPT/RI) - Segro Plc Replacement
3rd Jul 202611:58 amRNSForm 8.5 (EPT/RI) - Segro Plc
3rd Jul 202611:58 amPRNForm 8.3 - SEGRO plc
3rd Jul 202611:42 amRNSForm 8.5 (EPT/NON-RI) - SEGRO PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.